PE20081657A1 - Derivados de ftalazina como antagonistas de los receptores de histamina h1 - Google Patents

Derivados de ftalazina como antagonistas de los receptores de histamina h1

Info

Publication number
PE20081657A1
PE20081657A1 PE2008000040A PE2008000040A PE20081657A1 PE 20081657 A1 PE20081657 A1 PE 20081657A1 PE 2008000040 A PE2008000040 A PE 2008000040A PE 2008000040 A PE2008000040 A PE 2008000040A PE 20081657 A1 PE20081657 A1 PE 20081657A1
Authority
PE
Peru
Prior art keywords
alkyl
methyl
phthalazine
histamine
antagonists
Prior art date
Application number
PE2008000040A
Other languages
English (en)
Spanish (es)
Inventor
Paul Martin Gore
Michael Joachim Kranz
Brian Edgar Looker
Sadie Vile
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20081657A1 publication Critical patent/PE20081657A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PE2008000040A 2006-12-20 2008-01-02 Derivados de ftalazina como antagonistas de los receptores de histamina h1 PE20081657A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87087506P 2006-12-20 2006-12-20
US97844707P 2007-10-09 2007-10-09
US99122707P 2007-11-30 2007-11-30

Publications (1)

Publication Number Publication Date
PE20081657A1 true PE20081657A1 (es) 2008-12-23

Family

ID=39536783

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000040A PE20081657A1 (es) 2006-12-20 2008-01-02 Derivados de ftalazina como antagonistas de los receptores de histamina h1

Country Status (10)

Country Link
US (1) US20100184770A1 (enExample)
EP (1) EP2091538B1 (enExample)
JP (1) JP2010513393A (enExample)
AR (1) AR064424A1 (enExample)
AT (1) ATE459358T1 (enExample)
DE (1) DE602007005167D1 (enExample)
ES (1) ES2341813T3 (enExample)
PE (1) PE20081657A1 (enExample)
TW (1) TW200831493A (enExample)
WO (1) WO2008074803A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1873147A4 (en) * 2005-04-21 2010-01-06 Nippon Shinyaku Co Ltd PHTHALAZINON DERIVATIVE AND THEREOF PHARMACEUTICALS
US8466150B2 (en) * 2006-12-28 2013-06-18 Abbott Laboratories Inhibitors of poly(ADP-ribose)polymerase
PH12012501544A1 (en) * 2006-12-28 2024-06-03 Abbvie Inc Inhibitors of poly (adp-ribose) polymerase
ATE525370T1 (de) * 2007-10-11 2011-10-15 Glaxo Group Ltd Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten
WO2009150101A1 (en) * 2008-06-09 2009-12-17 Glaxo Group Limited Pharmaceutical compositions comprising n-[2-((2r)-2-{[4-[(4-chlorophenyl)methyl]-l-oxo-2(ih)-phthalaz inyl]methyl}-l- pyrrolidinyl)ethyl]-4-(methyloxy)butanamide
EP2323991B1 (en) * 2008-08-13 2017-05-31 Boehringer Ingelheim International GmbH Chymase inhibitors
WO2012045729A1 (en) 2010-10-05 2012-04-12 Glaxo Group Limited Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
WO2012072512A1 (en) 2010-11-29 2012-06-07 Glaxo Group Limited N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists
EP2697221A1 (en) 2011-04-11 2014-02-19 Glaxo Group Limited N- cyclobutyl - imidazopyridine - methylamine as trpv1 antagonists
EP4346815A4 (en) * 2021-05-27 2025-04-02 Schrödinger, Inc. HETEROCYCLIC COMPOUNDS AND METHODS OF USE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634942A1 (de) * 1985-11-11 1987-05-14 Asta Werke Ag Chem Fab Neue 4-benzyl-1-(2h)-phthalazinon-derivate
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
ES2209337T3 (es) * 1998-08-14 2004-06-16 Pfizer Inc. Agentes antitromboticos.
HUP0303193A3 (en) * 2001-02-15 2007-08-28 Altana Pharma Ag Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them
TWI347845B (en) * 2002-03-06 2011-09-01 Nycomed Gmbh Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
EP1617841A4 (en) * 2003-03-18 2008-08-13 Merck & Co Inc AMINO CYCLOBUTYLAMIDE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
EP1642898B1 (en) * 2003-06-27 2013-03-27 Msd K.K. Heteroaryloxy nitrogenous saturated heterocyclic derivative
EP1873147A4 (en) * 2005-04-21 2010-01-06 Nippon Shinyaku Co Ltd PHTHALAZINON DERIVATIVE AND THEREOF PHARMACEUTICALS
TW200811116A (en) * 2006-04-20 2008-03-01 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
AR064424A1 (es) 2009-04-01
TW200831493A (en) 2008-08-01
JP2010513393A (ja) 2010-04-30
EP2091538A2 (en) 2009-08-26
EP2091538B1 (en) 2010-03-03
WO2008074803A3 (en) 2008-09-18
US20100184770A1 (en) 2010-07-22
WO2008074803A8 (en) 2009-05-14
ES2341813T3 (es) 2010-06-28
DE602007005167D1 (de) 2010-04-15
WO2008074803A2 (en) 2008-06-26
ATE459358T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
PE20081657A1 (es) Derivados de ftalazina como antagonistas de los receptores de histamina h1
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
PE20090276A1 (es) Compuestos derivados de imidazoquinolina como moduladores de tlr7
PE20121613A1 (es) Derivados de quinolina amida como moduladores alostericos positivos de receptores m1
PE20091561A1 (es) Compuestos inhibidores de raf y metodos para su uso
PE20120321A1 (es) Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa
CR8505A (es) Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
PE20071223A1 (es) Procedimiento de preparacion de derivados de acil-amino-alquilen-amida
PE20070217A1 (es) Derivados de isoquinolona sustituidos con piperidinilo
PE20020858A1 (es) Indanil aminas aciladas
PE20121058A1 (es) Compuestos que modulan el receptor de androgenos
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
PE20061106A1 (es) Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida
PE20071156A1 (es) COMPUESTOS DERIVADOS DE 4,5,6,7-TETRAHIDRO-1H-INDAZOL COMO POTENCIADORES DEL RECEPTOR DEL ACIDO a-AMINO-3-HIDROXI-5-METILISOXAZOL-4-PROPIONICO (AMPA)
PE20090773A1 (es) Derivados de morfolina pirimidina
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20140623A1 (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20140207A1 (es) Composiciones y metodos para modular el fxr
AR063331A1 (es) Derivados de biaril eter urea y composiciones farmaceuticas
PE20131377A1 (es) Triazina-oxadiazoles
PE20140868A1 (es) Antagonistas trpm8 y su uso en tratamientos
PE20071254A1 (es) Derivados de sulfonamidas como agentes moduladores de los receptores de orexina y su preparacion
AR064547A1 (es) Derivados de azaspiro como antagonistas del receptor v1a

Legal Events

Date Code Title Description
FX Voluntary withdrawal